CAMBRIDGE, Mass., March 21, 2022 (Globe Newswire) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicine company committed to delivering life-changing treatments for people battling devastating diseases , announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer, will virtually participate in an analyst-led fireside chat at the Stifel 2022 CNS Days event on Monday, March 28, 2022 at 9:15 a.m. EDT are determined for.
A live webcast of the presentation will be available on the Investor Relations page of the Wave Life Sciences corporate website at http://ir.wavelifesciences.com. A replay of the presentation will be archived and available on that site for a limited time after the event.
About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage genetic medicine company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class drugs across multiple therapeutic modalities using the company’s proprietary discovery and drug development platform, which enables the precise design, optimization and production of stereopure oligonucleotides. Driven by a strong sense of urgency, the Wave team is targeting a wide range of genetically defined diseases to help patients and families realize a brighter future. To learn more, please visit www.wavelifesciences.com and follow Wave on Twitter @WaveLifeSci.
Investor Contact:
kate roush
617-949-4827
[email protected]
media Contact:
Alicia Sutter
617-949-4817
[email protected]
Stay Connected With Us On Social Media Platforms For Instant Updates Click Here To Connect With Us TeaveterAnd Facebook